M. Haas

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.

José Miguel Contreras, G. Lip, J. De Sutter, 2021, The lancet. Diabetes & endocrinology.

Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial.

Allison R. Schulman, C. Apovian, L. Aronne, 2019, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial

Joseph P. Glaser, C. Apovian, L. Aronne, 2016, The American Journal of Gastroenterology.

Aspiration Therapy for the Treatment of Obesity: 2-4 Year Results of the PATHWAY Multicenter Randomized Controlled Trial

Allison R. Schulman, C. Apovian, L. Aronne, 2018, Surgery for Obesity and Related Diseases.